These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

479 related articles for article (PubMed ID: 6230270)

  • 1. Platelets and diabetic vascular disease.
    Paton RC; Passa P
    Diabete Metab; 1983 Dec; 9(4):306-12. PubMed ID: 6230270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet aggregation, beta-thromboglobulin and platelet factor 4 in diabetes mellitus and in patients with vasculopathy.
    Fritschi J; Christe M; Lämmle B; Marbet GA; Berger W; Duckert F
    Thromb Haemost; 1984 Dec; 52(3):236-9. PubMed ID: 6241750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet and vessel wall interaction and the genesis of atherosclerosis.
    Chesterman CN; Berndt MC
    Clin Haematol; 1986 May; 15(2):323-53. PubMed ID: 2942331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The platelet-vessel wall interaction in experimental atherosclerosis and ischaemic heart disease with special reference to thrombopoiesis.
    Kristensen SD
    Dan Med Bull; 1992 Apr; 39(2):110-27. PubMed ID: 1611918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time course of changes in in vitro platelet function and plasma von willebrand factor activity (VIIIR:WF) and factor VIII-related antigen (VIIIR:Ag) in the diabetic rat.
    Winocour PD; Lopes-Virella M; Laimins M; Colwell JA
    J Lab Clin Med; 1983 Nov; 102(5):795-804. PubMed ID: 6415193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced platelet release reaction, shortened platelet survival time and increased platelet aggregation and plasma thromboxane B2 in chronic obstructive arterial disease.
    Zahavi J; Zahavi M
    Thromb Haemost; 1985 Feb; 53(1):105-9. PubMed ID: 3158092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ex vivo platelet studies following oral nisoldipine in normotensive insulin-dependent diabetics and non-diabetic controls.
    Hendra TJ; Oughton J; Jeremy JY; Smith CC; Betteridge DJ; Dandona P; Yudkin JS
    Diabetes Res; 1988 Jul; 8(3):117-22. PubMed ID: 2976336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet proteins (beta-TG and PF4) in atherosclerosis and related diseases.
    Mühlhauser I; Schernthaner G; Silberbauer K; Sinzinger H; Kaliman J
    Artery; 1980; 8(1):73-9. PubMed ID: 6158934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in some aspects of platelet function with improvement of glycaemic control over 6 months.
    Collier A; Tymkewycz PM; Matthews DM; Jones RL; Clarke BF
    Diabetes Res; 1987 Jun; 5(2):79-82. PubMed ID: 2443296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haemostasis in diabetics.
    Misz M; Beck P; Udvardy M; Rák K
    Acta Med Hung; 1984; 41(2-3):93-102. PubMed ID: 6235479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet abnormalities in diabetes mellitus.
    Glassman AB
    Ann Clin Lab Sci; 1993; 23(1):47-50. PubMed ID: 8431000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood and surface factors of importance for vascular surgery.
    Swedenborg J
    Acta Chir Scand Suppl; 1985; 529():3-6. PubMed ID: 3914153
    [No Abstract]   [Full Text] [Related]  

  • 13. Thrombus formation and platelet-vessel wall interaction in the nephrotic syndrome under flow conditions.
    Zwaginga JJ; Koomans HA; Sixma JJ; Rabelink TJ
    J Clin Invest; 1994 Jan; 93(1):204-11. PubMed ID: 8282789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostanoids and thromboxane A2 involvement in diabetic retinopathy.
    Naveh-Floman N; Moisseiev J
    Metab Pediatr Syst Ophthalmol; 1982; 6(3-4):321-5. PubMed ID: 6764248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Interactions between the platelets and the vessel wall. Part 1: Physiology (author's transl)].
    Tobelem G; Drouet L; Caen J
    Nouv Presse Med; 1980 Mar; 9(13):949-54. PubMed ID: 6987618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased platelet adenylate cyclase activity ion diabetic patients with microangiography.
    Janka HU; Standl E; Mehnert H
    Horm Metab Res Suppl; 1981; 11():26-9. PubMed ID: 6172351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Role of prostacyclin in the antiaggregation activity of the vascular wall].
    Gabrielian ES; Akopov SE; Balaian BG
    Biull Eksp Biol Med; 1984 Oct; 98(10):403-5. PubMed ID: 6388657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of calpain in diabetes-associated platelet hyperactivation.
    Randriamboavonjy V; Fleming I
    Adv Pharmacol; 2010; 59():235-57. PubMed ID: 20933204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet behaviour in non-insulin-dependent diabetes--influence of vascular complications, treatment and metabolic control.
    Peacock I; Hawkins M; Heptinstall S
    Thromb Haemost; 1986 Jun; 55(3):361-5. PubMed ID: 3092392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Vascular-platelet link in the hemostatic system of diabetics].
    Baluda VP; Deianov I; Balabolkin MI; Lukoianova TI; Baluda MV
    Probl Endokrinol (Mosk); 1986; 32(2):32-5. PubMed ID: 2940588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.